CSP-targeting functional antibody
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CSP-targeting functional antibody, covering 2024-01-29 to 2024-01-29. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 1/2, First-in-Human, Open Label, Dose Escalation Study Of A CSP Targeting Functional Antibody in Solid Tumors [Phase 1, Phase 2]